Tickers

1. Composite Trajectory Verdict

All three statements carry roughly equal weight for BEEM given its pre-profit, capital-intensive manufacturing model where revenue conversion, cash burn rate, and equity/working capital erosion collectively determine runway.

Composite Trajectory: Mixed

The annual income statement shows sharp deterioration: revenue fell 43% to $28.2M and net loss more than doubled to $27.0M (10-K FY2025, Consolidated Statements of Operations). Quarterly data provides a countervailing signal: Q2 2026 revenue rose 21% year-over-year to $8.6M, though YTD revenue remains 13% below the prior year (10-Q Q2 2026, Consolidated Statements of Operations). Cash flow deteriorated on an annual basis — operating cash burn widened from $2.2M to $10.5M — and YTD operating cash used increased to $4.8M from $2.1M, with the company reliant on ATM equity issuance ($5.2M YTD) to maintain a ~$1.0M cash balance (10-K FY2025, Consolidated Statements of Cash Flows; 10-Q Q2 2026, Consolidated Statements of Cash Flows). The balance sheet has weakened steadily: working capital dropped from $13.8M to $5.5M and total equity from $41.3M to $20.3M over the last 18 months (10-K FY2025, Consolidated Balance Sheets; 10-Q Q2 2026, Consolidated Balance Sheets). The improving quarterly revenue trend is offset by persistent losses, widening cash burn, and declining balance sheet capacity.

2. Red Flags

• Operating cash burn increased 5x year-over-year to $10.5M for FY2025 while revenue fell 43% (10-K FY2025, Consolidated Statements of Cash Flows).
• YTD Q2 2026 operating cash used ($4.8M) more than doubled versus YTD Q2 2025 ($2.1M) despite a lower net loss (10-Q Q2 2026, Consolidated Statements of Cash Flows).
• Goodwill of $10.8M was fully impaired in Q1 2025, eliminating all goodwill from the balance sheet; the impairment was triggered by market cap decline, not operating performance (10-K FY2025, MD&A / Results of Operations).
• Working capital has contracted 60% from $13.8M (Dec 2024) to $5.5M (Jun 2026) (10-K FY2025, Consolidated Balance Sheets; 10-Q Q2 2026, Consolidated Balance Sheets).
• The company has drawn zero on its $100M supply-chain credit facility since inception (March 2023) and relies on ATM equity sales for liquidity (10-K FY2025, Liquidity and Capital Resources; 10-Q Q2 2026, Note 2 Liquidity).
• Accounts receivable allowance for credit losses jumped from $939 (Dec 2025) to $2,779 (Jun 2026) with a $1.8M provision in H1 2026 (10-Q Q2 2026, Note Accounts Receivable).
• Federal government revenue collapsed from 32% of total in 2024 to 4% in 2025 and <1% in H1 2026 (10-K FY2025, MD&A; 10-Q Q2 2026, Note 12 Revenues).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual results deteriorated sharply: FY2025 revenue fell 43% to $28.2M from $49.3M, gross margin declined 2.3 percentage points to 12.5%, and net loss widened to $27.0M from $11.3M (10-K FY2025, Consolidated Statements of Operations). Excluding the $10.8M goodwill impairment, operating expenses were roughly flat at $20.3M vs $19.0M. Quarterly trends show divergence: Q2 2026 revenue increased 21% YoY to $8.6M with gross profit of $1.5M (17.8% margin), but YTD 2026 revenue is still 13% below YTD 2025 ($11.7M vs $13.4M) and YTD gross profit fell 42% to $1.1M (10-Q Q2 2026, Consolidated Statements of Operations). Net loss YTD improved to $9.9M from $19.8M, though the prior year included the $10.8M impairment; operating loss ex-impairment was $9.7M vs $9.2M. The loss per share narrowed to $(0.47) YTD from $(1.30) YTD 2025 (10-Q Q2 2026, Consolidated Statements of Operations).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Deteriorating

FY2025 operating cash burn widened to $10.5M from $2.2M in FY2024, driven by a $3.3M accounts payable decrease, $1.1M noncurrent liability decrease, and $0.5M receivables increase (10-K FY2025, Consolidated Statements of Cash Flows). Investing outflows slowed to $0.5M from $4.1M as acquisition spending ceased. Financing provided $7.5M, almost entirely from ATM equity sales ($7.8M). Cash ended FY2025 at $1.0M vs $4.6M. In H1 2026, operating cash used was $4.8M vs $2.1M in H1 2025, despite a smaller net loss; the increase reflects a $1.8M credit loss provision and $1.1M inventory reduction (10-Q Q2 2026, Consolidated Statements of Cash Flows). Financing supplied $5.2M from ATM sales, leaving cash essentially unchanged at $1.0M. The company has not accessed its $100M OCI credit facility (10-K FY2025, Liquidity and Capital Resources; 10-Q Q2 2026, Note 2).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Deteriorating

Total assets declined from $61.5M (Dec 2024) to $42.7M (Dec 2025) to $38.2M (Jun 2026) (10-K FY2025, Consolidated Balance Sheets; 10-Q Q2 2026, Consolidated Balance Sheets). Cash fell from $4.6M to $1.0M over 18 months. Inventory decreased from $12.3M to $8.3M, and accounts receivable from $8.0M to $6.7M. Current liabilities were relatively stable at ~$12.1M, but working capital contracted from $13.8M to $8.9M to $5.5M. Total equity dropped from $41.3M to $24.8M to $20.3M, driven by accumulated deficit growth ($104.6M → $131.6M → $141.6M) partially offset by ATM equity raises ($9.4M added to APIC in H1 2026) (10-K FY2025, Consolidated Statements of Operations; 10-Q Q2 2026, Consolidated Statements of Changes in Stockholders' Equity). Goodwill was fully written off ($10.8M). Debt remains minimal (~$0.2M notes payable). The leverage ratio (liabilities/equity) rose from 0.49x to 0.88x.

6. Data Gaps

• Standalone Q3 and Q4 2025 quarterly results (only FY2025 annual and Q1/Q2 2026 quarterly data provided; cannot isolate H2 2025 trends).
• Segment-level profitability or product-line gross margins (filings state single segment; no disaggregation beyond geography).
• Detailed breakdown of operating expenses (R&D vs SG&A) — only aggregated "Operating expenses excluding impairment" provided.
• Terms and covenants of the OCI $100M supply-chain facility beyond the description in the 10-K.
• Order backlog quantification (balance sheet shows $0 backlog intangible; no dollar backlog disclosed in notes).
• Cash flow statement for standalone Q2 2026 (only YTD provided in 10-Q).